The PCA3 test for guiding repeat biopsy of prostate cancer and its cut-off score: a systematic review and meta-analysis. - Wikidata - awgldk - TriplyDB

The PCA3 test for guiding repeat biopsy of prostate cancer and its cut-off score: a systematic review and meta-analysis.

The PCA3 test for guiding repeat biopsy of prostate cancer and its cut-off score: a systematic review and meta-analysis.

http://www.wikidata.org/entity/Q38203111

about

The Present and Future of Biomarkers in Prostate Cancer: Proteomics, Genomics, and Immunology Advancements Urinary biomarkers for prostate cancer PCA3 in prostate cancer and tumor aggressiveness detection on 407 high-risk patients: a National Cancer Institute experience Novel Gene Expression Signature Predictive of Clinical Recurrence After Radical Prostatectomy in Early Stage Prostate Cancer Patients.Long noncoding RNAs in prostate cancer: overview and clinical implications.Epigenomic Regulation of Androgen Receptor Signaling: Potential Role in Prostate Cancer Therapy.Recent progress and perspectives on prostate cancer biomarkers.Screening for Prostate Cancer-Beyond Total PSA, Utilization of Novel Biomarkers.Biomarkers in localized prostate cancer.Somatic Mutation Analyses in Studies of the Clonal Evolution and Diagnostic Targets of Prostate Cancer.Longitudinal assessment of urinary PCA3 for predicting prostate cancer grade reclassification in favorable-risk men during active surveillance.Prostate cancer antigen 3 and genetic risk score as markers for the detection of prostate cancer in the Chinese population.Prognostic value of urinary prostate cancer antigen 3 (PCA3) during active surveillance of patients with low-risk prostate cancer receiving 5α-reductase inhibitors.Urinary markers aiding in the detection and risk stratification of prostate cancer

P2860

Q26750672-30A781F4-5ADC-458B-ABE6-B495AAFE302B Q27009110-95B4E0BE-D858-44EC-891C-91F708D06256 Q35074229-FA049148-22F5-4092-A863-1C4BCB8E54F6 Q36043833-D3935024-4921-4CB3-A6E9-C42B140BB8C1 Q37113177-0EE53B97-83C9-45DF-88C6-C73656EC519D Q37629548-D466A813-0298-4935-9138-45012D80B965 Q37736079-69F05DF4-FD48-41F2-8020-14DC3597EE07 Q38546301-421E8789-8134-4F1A-BA73-9532B7048E7E Q38697114-55FEFBAC-5B10-4808-8E67-BFBA478A4A58 Q38703676-C6CD0733-7048-4718-B88A-877D04365BE7 Q40461863-1BCC8D5F-B613-4F09-A827-41461485D9ED Q43102971-04A92B54-1848-4A37-A4FB-417BB0814171 Q48252578-996143FF-3AF4-4DFE-AD52-1C82EB40EC4D Q58562073-CE998E4C-1692-485B-B661-AFAC509FACCC

P2860

The PCA3 test for guiding repeat biopsy of prostate cancer and its cut-off score: a systematic review and meta-analysis.

http://www.wikidata.org/entity/Q38203111

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

The PCA3 test for guiding repe ...... atic review and meta-analysis.

@en

type

label

The PCA3 test for guiding repe ...... atic review and meta-analysis.

@en

prefLabel

The PCA3 test for guiding repe ...... atic review and meta-analysis.

@en

P1433

Q38203111-5162672F-3C72-4BD0-A714-963799F64BB0

P1476

Q38203111-3F0C5FB5-7293-4E40-94F6-0C19F97D8B99

P2093

Q38203111-6315A080-8AF4-421C-BDFA-3F55D10F7832

Q38203111-AC6CDA12-AC8E-46EC-89E4-1A4F55830143

Q38203111-BC5B4743-0D7D-43B2-9BF9-A90EB08C18D5

Q38203111-DF0935CC-0A32-4EFE-AC71-51F9572CE326

P275

Q38203111-3B3F9289-A081-4715-BBA3-ED6935DE176F

P2860

Q38203111-032A7CD8-005F-459F-9FBD-959E4308B09A

Q38203111-05E56085-FA91-4ACD-989D-C48D34C1D2F0

Q38203111-0D6DA65F-8DCD-4366-8C9E-856B68DAF18B

Q38203111-14B4B5F6-A277-4BEF-86FB-5D4F26FE2CC6

Q38203111-18F33471-1ECE-4AAA-8076-2A7D424F17F4

Q38203111-1BB4ADDB-E19A-4BE7-86D4-83768E1D85C4

Q38203111-1FD91B5A-6252-408B-AB96-868C2333E926

Q38203111-227972AE-6980-469F-80C6-CB6251064126

Q38203111-28D0C41C-0E01-42D5-89A8-95FC44B59D51

Q38203111-46E25C4D-9F10-4EA2-8F99-095A0C22EF1D

P304

Q38203111-CBBB155B-E98F-4BAD-9750-96223FC865FA

P31

Q38203111-3AAB0F6E-B40C-4955-944D-5B64E82D2164

Q38203111-592FAC40-6629-43E3-A36E-7DC77FBC1EDA

Q38203111-6d5dfb0f-c959-447c-96af-8f5299d62aa6

P356

Q38203111-353B6707-91E3-4195-A580-5CDD4DC06F71

P433

Q38203111-A6E027D7-F07A-4263-B773-ECFFFBE00093

P478

Q38203111-AC3D7555-AFBF-42C8-98D0-E74220BBF126

P5008

Q38203111-616759A8-37FA-4313-BA91-186617D3429C

P577

Q38203111-A525EFE4-FA61-487A-9229-43014EE1E5A6

P5875

Q38203111-5E29D845-E628-4902-B724-A6FEBB50C7A6

P698

Q38203111-9987A3B0-7705-492F-B7C8-D33A36AE1F40

P921

Q38203111-0C017694-5F6E-4679-AD05-B2B2EC1E4AB5

Q38203111-63DA0AED-95AB-4BFA-825F-90A92B14E54A

Q38203111-AA71EA28-2114-4636-8A67-24CA5540AC7C

P932

Q38203111-5EE43641-FE13-442E-B2C1-D86A79D4479F

P356

1008-682X.125390

P1433

Asian Journal of Andrology

P1476

The PCA3 test for guiding repe ...... atic review and meta-analysis.

@en

P2093

Chan Mou

http://www.w3.org/2001/XMLSchema#string

Peng Huang

http://www.w3.org/2001/XMLSchema#string

Xin Gou

http://www.w3.org/2001/XMLSchema#string

Yong Luo

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported

P2860

Molecular cloning and characterization of STAMP1, a highly prostate-specific six transmembrane protein that is overexpressed in prostate cancer

Cancer statistics, 2012

Trp-p8, a novel prostate-specific gene, is up-regulated in prostate cancer and other malignancies and shares high homology with transient receptor potential calcium channel proteins.

A novel human prostate-specific gene-1 (HPG-1): molecular cloning, sequencing, and its potential involvement in prostate carcinogenesis.

DD3: a new prostate-specific gene, highly overexpressed in prostate cancer.

DD3(PCA3)-based molecular urine analysis for the diagnosis of prostate cancer.

Molecular cloning and characterization of STAMP2, an androgen-regulated six transmembrane protein that is overexpressed in prostate cancer.

PCA3 molecular urine assay for prostate cancer in men undergoing repeat biopsy.

PCA3: a molecular urine assay for predicting prostate biopsy outcome.

Clinical utility of the PCA3 urine assay in European men scheduled for repeat biopsy.

P304

487-492

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4103/1008-682X.125390

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P5008

P577

2014-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

261515877

http://www.w3.org/2001/XMLSchema#string

P698

24713827

http://www.w3.org/2001/XMLSchema#string

P921

prostate cancer

tumor biomarkers

P932

4023384

http://www.w3.org/2001/XMLSchema#string